IFFAS/AOFS/COFAS Webinar: Hallux Valgus

AGENDA

• Overview of the 2020-2021 IFFAS Webinar Series – Cristian A. Ortiz, MD, Manuel J. Pellegrini, MD
• Overview and Introduction of this Hallux Valgus Webinar – Mark E. Easley, MD, Monika Volesky, MD
• Background/Evolution of Hallux Valgus Correction - Michael J. Coughlin, MD
• Interactive Panel Discussion – Moderators: Mark E. Easley, MD, Monika Volesky, MD, Panelists – Gregory P. Guyton, MD, A. Holly Johnson, MD, Robert D. Santrock, MD, Alastair S.E. Younger, MBChB, ChM
• Insights and Observations for HV Pathology and Correction – Charles L. Saltzman, MD
• Points of Emphasis and Addressing Participant Questions - All faculty

Support for this webinar is provided by educational grants from:

Paragon 28

South Tech Orthopedics (exclusive distributor for Arthrex)

Treace Medical Concepts, Inc.

AOFAS Mission Statement

The mission of the American Orthopaedic Foot & Ankle Society is to improve lives through exceptional orthopaedic foot and ankle care.

Target Audience

This course is designed for the experienced foot and ankle surgeon, the generalist orthopaedic surgeon interested in expanding their scope of practice into foot and ankle, post-residency fellows and residents who treat acute and chronic problems of the foot and ankle, and allied health professionals who work in foot and ankle care.

Description

Part of the International Federation of Foot & Ankle Societies Webinar Series, this webinar will focus on current trends in hallux valgus correction with an emphasis on metatarsal rotation correction and minimally invasive surgery. Faculty will share their extensive experience, tips and tricks, and contributions to developing today's most advanced techniques. In addition, Dr. Coughlin will provide a historical perspective and his evolution of bunion correction, while Dr. Saltzman will offer his insight into hallux valgus biomechanics and pathology.

Course Objectives

At the conclusion of this webinar, you will be able to:

• Optimize minimally invasive surgical techniques in hallux valgus correction
• Understand the influence of metatarsal rotation on hallux valgus deformity and how to effectively correct it

Statement of Need

A need for this educational activity has been determined based on previous course/meeting evaluations, practice gap analysis, membership surveys, and the AOFAS educational curriculum. The content of this course was based on current issues and topics provided by AOFAS membership and leadership.

Program

The AOFAS attests that the person(s) responsible for the development of this educational activity did so independently and were not influenced by commercial supporters.

Accreditation

The American Orthopaedic Foot & Ankle Society (AOFAS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

Credit Designation Statement

The AOFAS designates this live activity for a maximum of 2 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Certificates

Participants are required to participate in the live program, answer the evaluation and claim CME at the end of the webinar.

Statement of Need

A need for this educational activity has been determined based on previous course evaluations and the AOFAS educational curriculum. The content of this course was based on current issues and topics provided by AOFAS membership and leadership. For more information on the AOFAS CME mission, visit aofas.org/education.

Accreditation

The American Orthopaedic Foot & Ankle Society (AOFAS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

Disclaimer

The material presented in this continuing medical education activity has been made available by the American Orthopaedic Foot & Ankle Society (AOFAS) for educational purposes only. This material is not intended to represent the only, nor necessarily the best, methods or procedures appropriate for the medical situation discussed, but rather is intended to present an approach, view, statement, or opinion of the authors or presenters, which may be helpful or of interest to other practitioners. Methods, techniques, and procedures demonstrated and views and opinions expressed by speakers, presenters, and faculty are their own, and do not necessarily represent those of AOFAS, nor does presentation on the program represent or constitute endorsement or promotion by AOFAS. AOFAS expressly disclaims any warranties or guarantees, expressed or implied, and shall not be liable for damages of any kind in connection with the material, methods, information, techniques, opinions, or procedures expressed, presented, or demonstrated.

Disclosure of Conflict of Interest

Disclosure Statement
AOFAS mandates all instructors, planners, and other individuals in a position to control or influence the content of an educational activity to disclose all financial relationships that you have had in the past 24 months with ineligible companies. An "ineligible company" is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All identified conflicts must be mitigated, and the education content vetted by the AOFAS for fair balance, scientific objectivity, and appropriateness. All disclosures will be provided in this final program distributed at the meeting to all program participants.

FDA Statement
Some drugs or medical devices demonstrated at this meeting have not been cleared by the FDA or have been cleared by the FDA for specific purposes only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or medical devices he or she wishes to use in clinical practice. AOFAS policy provides that "off label" uses of a drug or medical device may be described in its CME activities so long as the "off label" use of the drug or medical device is also specifically disclosed (i.e., it must be disclosed that the FDA has not cleared the drug or device for the described purpose). Any drug or medical device is being used "off label" if the described use is not set forth on the products approval label.

Faculty/Planner Disclosure Declaration
As an Accreditation Council for Continuing Medical Education (ACCME) provider, AOFAS has the obligation to ensure the delivery of education that is balanced and free of commercial bias. To achieve this, it is the policy of the AOFAS that all CME-related Board, committee members ("planners"), faculty, and appropriate staff disclose in writing to the learners all financial relationships that you have had in the past 24 months with ineligible companies. An "ineligible company" is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

In addition to faculty members, commentators from the floor are charged with verbally disclosing any interests immediately prior to speaking. All disclosures are provided in this final program distributed at the meeting to all program participants.

In accordance with AOFAS policy:
Faculty participation in this educational activity will be predicated upon timely submission and review of AOFAS disclosure. An individual who refuses to disclose relevant financial relationships will be disqualified from being a planning committee member, a teacher, or an author of CME, and cannot have control of, or responsibility for, the development, management, presentation, or evaluation of the CME activity. Non-compliance will result in a faculty member being stricken from the program.

An indication of the participant's disclosure appears after his or her name as well as the commercial company or institution that provided the support. AOFAS does not view the existence of these disclosed interests or commitments as necessarily implying bias or decreasing the value of the author's participation in this activity. In addition to ensuring that presentations be free of bias, faculty members are required to ensure that all material presented and discussed will be based on best-available evidence.

Webinar Faculty Disclosures

Mark E. Easley, MD
Exactech Inc. – Royalties, Paid Consultant, Research Support
Elsevier – Royalties, Financial or Material Support from Publishers
Journal of Bone and Joint Surgery – American – Medical, Orthopaedic publications editorial/governing board
IFFAS – Board member/committee appointments for a society

Monika Volesky, MD
This individual reported nothing to disclose.

Michael J. Coughlin, MD
Arthrex Inc. – Royalties, Speaker’s Bureau/Presenter, Paid Consultant
Stryker – Royalties, Speaker’s Bureau/Presenter
Integra – Royalties
Elsevier – Royalties, Royalties, Financial or Material Support from Publishers
Wright Medical Group N.V. - Royalties

Gregory P. Guyton, MD 
Wright Medical Group N.V. – Royalties
Arthrex Inc. – Royalties
Paragon28 – Speaker’s Bureau/Presenters, Paid Consultant
American Orthopaedic Foot and Ankle Society – Board member/committee appointments for a society

A. Holly Johnson, MD
Novastep – Royalties, Paid Consultant, Royalties, Financial or Material Support from Publishers
Medartis – Speaker’s Bureau/Presenter, Paid Consultant
Carbon 22 – Stock or Stock Options
Altier Trauma – Stock or Stock Options
American Orthopaedic Foot and Ankle Society – Board member/committee appointments for a society

Robert D. Santrock, MD 
Treace Medical Concepts – Royalties, Speaker’s Bureau/Presenter, Paid Consultant
Exactech – Speaker’s Bureau/Presenter, Paid Consultant
Epic Exxtermity – Stock or Stock Options

Alastair S.E. Younger, MBChB, ChM
Lippincott – Royalties
Wright Medical Group N.V. – Speaker’s Bureau/Presenter, Paid Consultant, Research Support
Stryker – Speaker’s Bureau/Presenter, Other Financial or Material Support
Zimmer – Paid Consultant, Research Support
Axolotyl – Paid Consultant, Research Support 
Acumed LLC – Research Support
Arthrex Inc. – Research Support
Saunders/Mosby-Elsevier – Royalties, Financial or Material Support from Publishers
Foot and Ankle International – Medical/Orthopaedic publications editorial/governing board
Canadian Orthopaedic Association – Board member/committee appointments for a society
American Orthopaedic Foot and Ankle Society – Board member/committee appointments for a society

Charles L. Saltzman, MD
Zimmer – Royalties
Wolters Kluwer Health – Lippincott Williams & Wilkins – Royalties, Financial or Material Support from Publishers
Foot and Ankle International – Medical/Orthopaedic publications editorial/governing board
American Board of Orthopaedic Surgery Inc. – Board member/committee appointments for a society

Cristian A. Ortiz, MD
Arthrex Inc. – Speaker’s Bureau/Presenter
Synthes – Unpaid Consultant
Acumed LLC – Unpaid Consultant
American Orthopaedic Foot and Ankle Society – Board member/committee appointments for a society
International Federation of foot and ankle societies – Board member/committee appointments for a society

Manuel J. Pellegrini, MD
Arthrex Inc. – Paid Consultant
Wright Medical Group N.V. – Paid Consultant
Acumed LLC – Paid Consultant

EDUCATION COMMITTEE DISCLOSURES (Planners)    

Jonathon D. Backus, MD
American Orthopaedic Foot and Ankle Society: Board or committee member
Foot and Ankle International: Editorial or governing board
Medline UNITE: Paid Consultant

W Hodges Davis, MD
AAOS: Board or committee member
American Orthopaedic Foot and Ankle Society: Board or committee member
Artelon: Paid Consultant
Amniox: Paid consultant; Research support
Arthrex, Inc: IP royalties; Paid consultant; Research support
DJ Orthopaedics: IP royalties; Other financial or material support; Paid consultant Foot and Ankle International: Editorial or governing board
Nuvasive: Paid consultant
Wright Medical Technology, Inc.: IP royalties; Other financial or material support; Paid consultant; 

Scott Ellis, MD
American Orthopaedic Foot and Ankle Society: Board or committee member
Foot and Ankle Online: Editorial or governing board
Paragon 28: Paid consultant
Wright Medical Technology, Inc.: Paid consultant

Daniel C Farber, MD
AAOS: Board or committee member
American Orthopaedic Foot and Ankle Society: Board or committee member
DJ Orthopaedic Foot and Ankle Society: Board or committee member
Foot and Ankle Online: Editorial or governing board
JMEA: Stock or stock Options
Trace Medical Concepts: Paid consultant

Alena Frey
Staff
This individual reported nothing to disclose

Lauren Elizabeth Geaney, MD 
American Orthopaedic Foot and Ankle Society: Board or committee member 
Arthrex, Inc: Research support
Connecticut Orthopaedic Society: Board or committee member Paragon 28: Paid consultant
Techniques in Orthopaedics: Editorial or governing board

Thomas M Hearty, MD
American Orthopaedic Foot and Ankle Society: Board or committee member 
Orthobullets: Editorial or governing board

Kelly K. Hynes, MD
This individual reported nothing to disclose

Anish Raj Kadakia, MD
AAOS: Board or committee member Acumed, LLC: IP royalties
American Orthopaedic Foot and Ankle Society: Board or committee member 
Arthrex, Inc: Paid consultant; Paid presenter or speaker; Research support 
Biomedical Enterprises: IP royalties 
DePuy, A Johnson & Johnson Company: IP royalties 
Elsevier: Publishing royalties, financial or material support 
LWW: Publishing royalties, financial or material support

James Robert Lachman, MD
This individual reported nothing to disclose

Elizabeth Martin, MD
American Orthopaedic Foot and Ankle Society: Board or committee member 

G Andrew Murphy, MD
Allostem,: Research support
American Orthopaedic Foot and Ankle Society: Board or committee member
Arthrex, Inc: Research support
Biomimetic: Research support
Ferring Pharmaceuticals: Research support
Foot and Ankle International: Editorial or governing board
Saunders/Mosby-Elsevier: Publishing royalties, financial or material support
Smith & Nephew: Research support
Wright Medical Technology, Inc.: IP royalties; Paid consultant; Paid presenter or speaker; Research support

Julie Murkowski
Staff
This individual reported nothing to disclose

Irvin Oh, MD
Innomed: IP royalties

Christian A. Ortiz, MD
This individual reported nothing to disclose

Vinod Kumar Panchbhavi, MD, FACS
AAOS: Board or committee member
American Orthopaedic Foot and Ankle Society: Board or committee member
Foot and Ankle InternationalTechniques in Foot & Ankle SurgeryOrthopedia.com: Editorial or governing board 
Stryker: Paid presenter or speaker
Wolters Kluwer Health - Lippincott Williams & Wilkins: Publishing royalties, financial or material support

Ruth Lourdes Thomas, MD
AAOS: Board or committee member
American Orthopaedic Foot and Ankle Society: Board or committee member Foot and Ankle International: Editorial or governing board
Johnson & Johnson: Stock or stock Options 
Pfeizer: Stock or stock Options
Ruth Jackson Orthopaedic Society: Board or committee member 
Stryker: Stock or stock Options Teva: Stock or stock Options 
Zimmer: Stock or stock Options

David B Thordarson, MD
American Orthopaedic Foot and Ankle Society: Board or committee member 
Bio 2: Stock or stock Options
Foot and Ankle International: Editorial or governing board; Publishing royalties, financial or material support 
Paragon 28: Research support; Stock or stock Options
Stryker: Paid consultant; Paid presenter or speaker

João Filipe Vide, MD
American Orthopaedic Foot and Ankle Society: Board or committee member
European Federation of National Associations of Orthopedics and Traumatology: Board or committee member

Brian M Weatherford, MD
BESPA Global: Paid consultant 
Orthobullets: Paid consultant 
Synthes: Paid presenter or speaker

Wang Xu, MD
This individual reported nothing to disclose

Jacob Rothschild Zide, MD
Orthofix: Paid consultant